An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
LENSAR to Participate in Two Upcoming Investor Conferences
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
LENSAR, Inc. (NASDAQ: LNSR), a medical technology company specializing in femtosecond laser solutions for cataract treatment, will have CEO Nick Curtis participate in two investor conferences. The first is the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 16 at 9:30 a.m. ET, and the second is the 11th Annual SVB Leerink Global Healthcare Conference on February 17 at 2:20 p.m. ET. The SVB Leerink chat can be accessed via LENSAR's website, and the recording will be available for a month post-event.
Positive
None.
Negative
None.
ORLANDO, Fla.--(BUSINESS WIRE)--
LENSAR, Inc. (NASDAQ: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced Nick Curtis, Chief Executive Officer, will participate in two upcoming investor conferences:
BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference Fireside Chat on Wednesday, February 16 at 9:30 a.m. Eastern Time
11th Annual SVB Leerink Global Healthcare Conference Fireside Chat on Thursday, February 17 at 2:20 p.m. Eastern Time
The SVB Leerink fireside chat can be accessed live through the Investors section of the Company's website at https://ir.lensar.com. The webcast will be available for one month after the presentation has been posted.
BTIG hosted events are intended for prospective and existing BTIG clients only. To listen to the event, please contact your BTIG representative with interest.
About LENSAR
LENSAR is a commercial-stage medical device company focused on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining better visual outcomes, efficiency and reproducibility by providing advanced imaging, simplified procedure planning, efficient design and precision.